ClinicalTrials.govpublic full text
Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)
cystic fibrosis, exocrine pancreatic insufficiency, ultrase® mt20, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 858745
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.